Resumen:
The Peritumoral Brain Zone (PBZ) contributes to Glioblastoma (GBM)
relapse months after the resection of the original tumor, which is influenced by a
variety of pathological factors. Among those, microglia are recognized as one of the
main regulators of GBM progression and probably relapse. Although microglial
morphology has been analyzed inside GBM and its immediate surroundings, it has
not been objectively characterized throughout the PBZ. Thus, we aimed to perform
a thorough characterization of microglial morphology in the PBZ and its likely
differentiation not just from the tumor-associated microglia but from control tissue
microglia. For this purpose, Sprague Dawley rats were intrastriatally implanted with
C6 cells to induce a GBM formation. Gadolinium-based magnetic resonance imaging
(MRI) was performed to locate the tumor and to define the PBZ (2 mm beyond the
tumor border), thus delimitating the different regions of interest (ROIs: core tumoral
zone and immediate interface; contralateral striatum as control). Brain slices were
obtained and immunolabeled with the microglia marker Iba-1. Sixteen morphological
parameters were measured for each cell, significative differences were found in all
parameters when comparing the four ROIs. To determine if PBZ microglia could be
morphologically differentiated from microglia in other ROIs, hierarchical clustering
analysis was performed, revealing that microglia can be separated into four
morphologically differentiated clusters, each of them mostly integrated by cells
sampled in each ROI. Furthermore, a classifier based on linear discriminant analysis,
including only three morphological parameters, categorized microglial cells across
the studied ROIs and showed a gradual transition between them. The robustness of
this classification was assessed through principal component analysis with the
remaining 13 morphological parameters, corroborating the obtained results. Thus, in
this study we provided objective and quantitative evidence that PBZ microglia
represent a differentiable microglial morphotype that could contribute to the
recurrence of GBM in this area.